DECIPHER LABS LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.5 INR | -1.18% |
|
-5.95% | +6.14% |
| Apr. 30 | Decipher Labs Limited Announces Change in Registered Office Address | CI |
| Feb. 14 | Decipher Labs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
| Sales 2022 | 653M 7.82M | Sales 2023 | 456M 5.46M | Capitalization | 143M 1.72M |
|---|---|---|---|---|---|
| Net income 2022 | 114M 1.37M | Net income 2023 | -26M -311K | EV / Sales 2022 | 0.74 x |
| Net cash position 2022 | 50.87M 609K | Net cash position 2023 | 64.68M 775K | EV / Sales 2023 | 0.17 x |
| P/E ratio 2022 |
4.7
x | P/E ratio 2023 |
-5.33
x | Employees | 5 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 76.21% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.98% | ||
| 1 week | -2.95% | ||
| Current month | +15.42% | ||
| 1 month | +27.69% | ||
| 3 months | +23.24% | ||
| 6 months | +9.09% | ||
| Current year | +9.52% |
1 week
18.10
20.70
1 month
14.4424.60
Current year
14.4425.75
1 year
14.4425.75
3 years
12.00145.70
5 years
12.00145.70
10 years
3.49145.70
| Managers | Title | Age | Since |
|---|---|---|---|
Sonam Jalan
DFI | Director of Finance/CFO | - | 19-03-26 |
| Compliance Officer | - | - | |
| Director/Board Member | 44 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 56 | 20-09-30 | |
| Director/Board Member | 65 | 22-08-12 | |
| Director/Board Member | 44 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-24 | 18.5 | -1.18% | 8 984 |
| 24-06-21 | 18.72 | -0.58% | 49,102 |
| 24-06-20 | 18.83 | -1.10% | 42,276 |
| 24-06-19 | 19.04 | -3.20% | 43,113 |
| 24-06-18 | 19.67 | -2.09% | 28,223 |
Delayed Quote Bombay S.E., June 23, 2024 at 11:58 pm EDT
More quotes
Decipher Labs Limited is an India-based company, which is engaged in the manufacture and marketing of pharmaceuticals and allied products and services. It also provides services to the information technology industry. The Company also caters to various formulators, manufacturers and research and development agencies for their bulk needs and sources and supplies various drugs and allied chemicals and allied products and services to the companies upon request. The Company offers a range of services, including technology integration and systems consulting, software development consulting, and management of information technology (IT) projects. The Companyâs wholly owned subsidiaries include ICP Solutions Private Limited and Decipher Software Solutions LLC.
Sector
Pharmaceuticals
Calendar
2024-08-11
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +9.52% | 2.26M | |
| +18.03% | 42.12B | |
| +23.46% | 21.72B | |
| +21.14% | 15.75B | |
| +21.24% | 14.89B | |
| +56.86% | 13.06B | |
| -0.05% | 6.79B | |
| -12.98% | 6.3B | |
| +20.03% | 6.05B | |
| -8.87% | 5.73B |
- Stock Market
- Equities
- COMBDRG Stock
